Status:
RECRUITING
Electroacupuncture Pain Treatment, Mechanical Hyperalgesia, Quality of Life & Expression of Mu+ B Cells in Fibromyalgia
Lead Sponsor:
University of Crete
Collaborating Sponsors:
University Hospital of Crete
Conditions:
Fibromyalgia
Electroacupuncture
Eligibility:
All Genders
18-80 years
Brief Summary
Fibromyalgia (FM) is a complex, multifactorial syndrome characterized by widespread chronic pain with hyperal- gesia and allodynia and a constellation of somatic and psychological manifestations, incl...
Detailed Description
The International Association for the Study of Pain (IASP) defined chronic pain as pain that persists or recurs for more than three months. In the case of conditions such as FM, it can be conceived as...
Eligibility Criteria
Inclusion
- Patient's consent
- Age \>18 years old
- Patients with diagnosed fibromyalgia from rheumatologists
- Widespread pain more than 6 months
- In case of drug therapy, it should be taken at least one month before the beginning of the session and remain stable till the end of the study
Exclusion
- Deep depression
- Biological agent use ( TNF inhibitors)
- Heamatological diseases
- Systemic Infections
- pregnancy
- electroacupuncture contraindications (epilepsy, pacemaker/ implantable cardioverter defibrillator (ICD)
Key Trial Info
Start Date :
May 31 2022
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 1 2026
Estimated Enrollment :
80 Patients enrolled
Trial Details
Trial ID
NCT05357157
Start Date
May 31 2022
End Date
December 1 2026
Last Update
October 26 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University Hospital of Heraklion
Heraklion, Greece, 700 13